학술논문
Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer with Central Nervous System Metastases for Patients Currently or Previously Treated with Trastuzumab (LANTERN): a Phase II Randomised Trial
Document Type
Article
Author
Source
In Clinical Oncology October 2020 32(10):656-664
Subject
Language
ISSN
0936-6555